We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Zotefoams Plc | LSE:ZTF | London | Ordinary Share | GB0009896605 | ORD 5P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.00 | -0.46% | 430.00 | 426.00 | 433.00 | 430.00 | 428.00 | 430.00 | 93,665 | 16:35:21 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Plastics Foam Products | 126.98M | 9.24M | 0.1892 | 22.62 | 209.06M |
From May 2019 to May 2024
TIDMZTF
RNS Number : 2514Z
Zotefoams PLC
14 December 2017
Zotefoams plc
("Zotefoams" or the "Company" or "Group")
GBP12 MILLION INVESTMENT PLANNED
TO BOOST MANUFACTURING CAPACITY AT CROYDON FACILITY
14 December 2017 - Zotefoams, a world leader in cellular materials technology, is pleased to announce that it will invest approximately GBP12 million to increase capacity at its Croydon, UK site.
Over the past few years demand for High-Performance Products (HPP) has increased and with strong customer interest in this product range we expect demand to continue to grow significantly.
The planned investment announced today is to install low-pressure ("LP") autoclaves intended primarily for expansion of ZOTEK(R) HPP foams. The Company currently operates four smaller LP autoclaves for this range of products, two of which were commissioned in early 2017. The investment, in two larger LP autoclaves, buildings and associated infrastructure, will increase expansion capacity for the ZOTEK(R) foams product range by a factor of up to six times.
The Company expects the enhanced capacity to come on stream during 2019.
Commenting on the investment David Stirling, Group CEO of Zotefoams, said:
"Our pipeline of opportunities to sell higher margin HPP materials is developing very positively and, with strong customer interest in our products, we believe that now is the right time to invest in increased manufacturing capacity to support our future growth."
Hot Features
Premium
Enquiries: Zotefoams +44 (0) 208 664
plc 1600
David Stirling, Group CEO
Gary McGrath, Group CFO
+44 (0) 203 053
IFC Advisory 8671
Graham Herring
Miles Nolan
About Zotefoams plc
Zotefoams plc (LSE - ZTF) is a world leader in cellular materials technology. Using a unique manufacturing process with environmentally friendly nitrogen expansion, Zotefoams produces and sells lightweight AZOTE(R) polyolefin and ZOTEK(R) high-performance foams for diverse markets worldwide. Zotefoams uses its own cellular materials to manufacture T-FIT(R) advanced insulation for demanding industrial markets. In addition, Zotefoams owns and licenses patented MuCell(R) microcellular foam technology, developed specifically for extrusion applications, from a base in Massachusetts, USA to customers worldwide.
Zotefoams is headquartered in Croydon, UK, with additional manufacturing sites in Kentucky and Oklahoma, USA (foam products manufacture and conversion), Massachusetts, USA (MuCell Extrusion) and Jiangsu Province, China (T-FIT(R)).
www.zotefoams.com
AZOTE(R), ZOTEK(R), T-FIT(R) are registered trademarks of Zotefoams plc
MuCell(R) is a registered trademark of Trexel Inc.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCFFLFEDFWSEEE
(END) Dow Jones Newswires
December 14, 2017 02:00 ET (07:00 GMT)
1 Year Zotefoams Chart |
1 Month Zotefoams Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
